Learning Objectives:

1. Describe the types of DMARDs used in rheumatic diseases and their mechanisms.

2. Learn about the evidence regarding the efficacy of DMARDs

3. Be familiar with their potential adverse effects and monitoring strategies.

Session date: 
Tuesday, September 10, 2019 - 9:30am to 10:30am
Speaker Name: 
Marco Lopez-Velazquez, M.D.
UCMC N-002
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.